Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 6 | 2025 | 746 | 1.520 |
Why?
|
| Single-Cell Analysis | 7 | 2025 | 114 | 1.380 |
Why?
|
| Prefrontal Cortex | 3 | 2025 | 121 | 1.070 |
Why?
|
| Neurons | 10 | 2025 | 922 | 1.040 |
Why?
|
| Brain | 3 | 2025 | 1554 | 0.950 |
Why?
|
| Genome, Human | 3 | 2025 | 237 | 0.890 |
Why?
|
| Genomics | 2 | 2025 | 370 | 0.800 |
Why?
|
| Transcriptome | 1 | 2025 | 388 | 0.740 |
Why?
|
| Whole Genome Sequencing | 6 | 2025 | 81 | 0.740 |
Why?
|
| DNA Repair | 3 | 2022 | 236 | 0.690 |
Why?
|
| Mutation Rate | 3 | 2022 | 23 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2022 | 491 | 0.600 |
Why?
|
| Mutation | 5 | 2025 | 2607 | 0.590 |
Why?
|
| Neurogenesis | 1 | 2017 | 64 | 0.530 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 143 | 0.480 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 260 | 0.430 |
Why?
|
| Ataxia Telangiectasia | 2 | 2023 | 12 | 0.410 |
Why?
|
| DNA Damage | 3 | 2022 | 280 | 0.360 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 878 | 0.360 |
Why?
|
| DNA Mutational Analysis | 4 | 2019 | 195 | 0.320 |
Why?
|
| Infant | 2 | 2025 | 1650 | 0.270 |
Why?
|
| Child, Preschool | 2 | 2025 | 1989 | 0.260 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2023 | 42 | 0.240 |
Why?
|
| Adolescent | 3 | 2025 | 6241 | 0.230 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 721 | 0.210 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 771 | 0.200 |
Why?
|
| DNA Copy Number Variations | 2 | 2020 | 72 | 0.200 |
Why?
|
| DNA Repair-Deficiency Disorders | 1 | 2022 | 1 | 0.200 |
Why?
|
| Microglia | 2 | 2023 | 242 | 0.190 |
Why?
|
| Child | 2 | 2025 | 4525 | 0.190 |
Why?
|
| Point Mutation | 1 | 2022 | 166 | 0.190 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 5452 | 0.190 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 96 | 0.190 |
Why?
|
| Young Adult | 2 | 2025 | 4686 | 0.180 |
Why?
|
| Infant, Newborn | 1 | 2025 | 1356 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 313 | 0.170 |
Why?
|
| Hippocampus | 2 | 2022 | 270 | 0.160 |
Why?
|
| Parkinson Disease | 2 | 2019 | 131 | 0.160 |
Why?
|
| Humans | 13 | 2025 | 63299 | 0.160 |
Why?
|
| Cockayne Syndrome | 1 | 2017 | 1 | 0.140 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2017 | 4 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2011 | 347 | 0.140 |
Why?
|
| Mosaicism | 1 | 2017 | 30 | 0.130 |
Why?
|
| DNA Replication | 2 | 2017 | 235 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 48 | 0.130 |
Why?
|
| Cell Lineage | 2 | 2015 | 268 | 0.130 |
Why?
|
| Histones | 2 | 2010 | 482 | 0.130 |
Why?
|
| Aged | 2 | 2025 | 14396 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 107 | 0.120 |
Why?
|
| Male | 3 | 2025 | 29823 | 0.120 |
Why?
|
| Genetic Loci | 1 | 2015 | 115 | 0.120 |
Why?
|
| Fibroblasts | 3 | 2011 | 387 | 0.120 |
Why?
|
| Adult | 2 | 2025 | 16788 | 0.110 |
Why?
|
| Middle Aged | 2 | 2025 | 17556 | 0.110 |
Why?
|
| Female | 3 | 2025 | 32793 | 0.110 |
Why?
|
| Mitosis | 1 | 2015 | 215 | 0.110 |
Why?
|
| Age Factors | 1 | 2017 | 1558 | 0.100 |
Why?
|
| Nucleotides | 2 | 2022 | 48 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2011 | 1348 | 0.090 |
Why?
|
| Dopaminergic Neurons | 1 | 2011 | 38 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2010 | 107 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2010 | 640 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2011 | 147 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2017 | 792 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2008 | 5 | 0.070 |
Why?
|
| Cellular Reprogramming | 1 | 2008 | 37 | 0.070 |
Why?
|
| Doxycycline | 1 | 2008 | 46 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 74 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 157 | 0.070 |
Why?
|
| DNA | 2 | 2022 | 832 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 290 | 0.070 |
Why?
|
| Mutagens | 1 | 2022 | 19 | 0.050 |
Why?
|
| INDEL Mutation | 1 | 2022 | 19 | 0.050 |
Why?
|
| Exons | 1 | 2022 | 199 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 296 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2020 | 65 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2022 | 469 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 934 | 0.040 |
Why?
|
| Mice | 5 | 2011 | 10816 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 169 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1380 | 0.040 |
Why?
|
| Quality Control | 1 | 2018 | 74 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 413 | 0.030 |
Why?
|
| Germ Cells | 1 | 2017 | 110 | 0.030 |
Why?
|
| Nerve Net | 1 | 2017 | 97 | 0.030 |
Why?
|
| Cell Division | 1 | 2017 | 449 | 0.030 |
Why?
|
| Animals | 5 | 2011 | 20619 | 0.030 |
Why?
|
| Software | 1 | 2018 | 389 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 3388 | 0.020 |
Why?
|
| Lewis X Antigen | 1 | 2011 | 6 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2011 | 12 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Teratoma | 1 | 2011 | 13 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2011 | 40 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Embryo Transfer | 1 | 2011 | 25 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 96 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 236 | 0.020 |
Why?
|
| Blastocyst | 1 | 2011 | 72 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 121 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 255 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 364 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 266 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 2008 | 18 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 42 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 676 | 0.020 |
Why?
|
| Lentivirus | 1 | 2008 | 66 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 263 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 187 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2151 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2036 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 1397 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 618 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 385 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 1275 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1602 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 609 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 1513 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1177 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 872 | 0.010 |
Why?
|